82256 Federal Register / Vol. 89, No. 197 / Thursday, October 10, 2024 / Notices 

the complaint with respect to the 

respondents other than Micron. 

On September 12, 2024, the ALJ 

issued the subject ID granting the joint 

motion to terminate the investigation. 

The ALJ found that the motion 

complied with the requirements of 

Commission Rule 210.21(b)(1) (19 CFR 

210.21(b)(1)) with respect to the 

termination of Micron based on a 

settlement agreement, and the motion 

complied with the requirements of 

Commission Rule 210.21(a)(1) (19 CFR 

210.21(a)(1)) with respect to the 

termination of the remaining 

respondents by withdrawal of the 

complaint. No petitions for review of 

the ID were filed. 

The Commission has determined not 

to review the subject ID. The 

investigation is hereby terminated in its 

entirety. 

The Commission vote for this 

determination took place on October 4, 

2024. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: October 4, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–23403 Filed 10–9–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1352] 

Certain Selective Thyroid Hormone 

Receptor-Beta Agonists, Processes for 

Manufacturing or Relating to Same, 

and Products Containing Same; Notice 

of Request for Submissions on the 

Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that on 

October 3, 2024, the presiding Chief 

Administrative Law Judge (‘‘Chief ALJ’’) 

issued an Initial Determination on 

Violation of Section 337. The Chief ALJ 

also issued a Recommended 

Determination on remedy and bonding 

should a violation be found in the 

above-captioned investigation. The 

Commission is soliciting submissions 

on public interest issues raised by the 

recommended relief should the 

Commission find a violation. This 

notice is soliciting comments from the 

public and interested government 

agencies only. 

FOR FURTHER INFORMATION CONTACT: 

Houda Morad, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

708–4716. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States 

unless, after considering the effect of 

such exclusion upon the public health 

and welfare, competitive conditions in 

the United States economy, the 

production of like or directly 

competitive articles in the United 

States, and United States consumers, it 

finds that such articles should not be 

excluded from entry. (19 U.S.C. 

1337(d)(1)). A similar provision applies 

to cease and desist orders. (19 U.S.C. 

1337(f)(1)). 

The Commission is soliciting 

submissions on public interest issues 

raised by the recommended relief 

should the Commission find a violation, 

specifically: a limited exclusion order 

directed to certain selective thyroid 

hormone receptor-beta agonists, 

processes for manufacturing or relating 

to same, and products containing same, 

imported, sold for importation, and/or 

sold after importation by respondents 

Ascletis Pharma Inc., Ascletis 

Pharmaceuticals Co. Ltd., Ascletis 

Bioscience Co., Ltd., Gannex Pharma 

Co., Ltd., and Jinzi Jason Wu 

(collectively, ‘‘Respondents’’), and cease 

and desist orders against the 

Respondents. Parties are to file public 

interest submissions pursuant to 19 CFR 

210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public and 

interested government agencies are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the Chief ALJ’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on October 3, 2024. 

Comments should address whether 

issuance of the recommended remedial 

orders in this investigation, should the 

Commission find a violation, would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) explain how the articles potentially 

subject to the recommended remedial 

orders are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on 

November 4, 2024. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 (Mar. 

19, 2020). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1352’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

secretary/fed_reg_notices/rules/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding filing 

should contact the Secretary (202–205– 

2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 197 / Thursday, October 10, 2024 / Notices 82257 

210.5(e)(2)). Documents for which 

confidential treatment by the 

Commission is properly sought will be 

treated accordingly. Any non-party 

wishing to submit comments containing 

confidential information must serve 

those comments on the parties to the 

investigation pursuant to the applicable 

Administrative Protective Order. A 

redacted non-confidential version of the 

document must also be filed 

simultaneously with any confidential 

filing and must be served in accordance 

with Commission Rule 210.4(f)(7)(ii)(A) 

(19 CFR 210.4(f)(7)(ii)(A)). All 

information, including confidential 

business information and documents for 

which confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

Government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: October 4, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–23422 Filed 10–9–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1406] 

Certain Memory Devices and 

Electronic Devices Containing the 

Same; Notice of a Commission 

Determination Not To Review an Initial 

Determination Terminating an 

Investigation Based on a Settlement 

Agreement; Termination of 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined not to review an initial 

determination (‘‘ID’’) (Order No. 10) of 

the presiding administrative law judge 

(‘‘ALJ’’) granting a joint motion to 

terminate the investigation based on a 

settlement agreement. The investigation 

is terminated. 

FOR FURTHER INFORMATION CONTACT: 

Lynde Herzbach, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3228. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on July 9, 2024, based on a complaint 

filed by MimirIP LLC of Dallas, Texas 

(‘‘Complainant’’ or ‘‘Mimir’’). 89 FR 

56406–407 (July 9, 2024). The 

complaint, as supplemented, alleges 

violations of section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, in the importation into the United 

States, the sale for importation, or the 

sale within the United States after 

importation of certain memory devices 

and electronic devices containing the 

same by reason of the infringement of 

certain claims of U.S. Patent Nos. 

7,468,928; 7,579,846; and 8,036,053. Id. 

The complaint further alleges that a 

domestic industry exists. Id. The 

Commission’s notice of investigation 

named as respondents Micron 

Technology Inc. of Boise, Idaho; Hewlett 

Packard Enterprise Co. of Spring, Texas; 

HP, Inc. of Palo Alto, California; 

Kingston Technology Company, Inc. of 

Fountain Valley, California; Lenovo 

Group Limited of Hong Kong; Lenovo 

(United States) Inc. of Morrisville, North 

Carolina; and Tesla Inc. of Austin, 

Texas. Id. The Office of Unfair Import 

Investigations (‘‘Staff’’) is participating 

in the investigation for issues relating to 

the economic prong of the domestic 

industry requirement, remedy, and 

public interest only. EDIS Doc. ID 

826262 (July 17, 2024). 

The Commission previously 

terminated respondent Lenovo Group 

Limited from this investigation and 

amended the complaint and the notice 

of investigation to add Lenovo PC HK 

Limited of Hong Kong and Lenovo 

Global Technology (United States) Inc. 

of Morrisville, North Carolina as 

respondents. Order No. 8 (Aug. 8, 2024), 

unreviewed by 89 FR 68645 (Aug. 27, 

2024). 

On August 27, 2024, Complainant and 

respondent Micron Technology, Inc. 

jointly moved for termination of this 

investigation in its entirety based on 

settlement agreements, which are ‘‘a 

[sublicense] agreement between Mimir 

and SK hynix Inc. and a patent license 

agreement between SK hynix and 

Micron.’’ ID at 1 n. 1 (citing Mot. at 2). 

The joint motion notes that it is ‘‘based 

on an agreement between Mimir and SK 

hynix and an agreement between SK 

hynix and Micron, which ‘collectively 

resolve all claims in the complaint 

asserted against all Respondents in this 

Investigation.’ ’’ Id. at 2 (citing Mot. at 

2). The joint motion notes that it is not 

opposed by the non-moving 

respondents, Hewlett Packard 

Enterprise Co., HP Inc., Kingston 

Technology Company, Inc., Lenovo PC 

HK Limited, Lenovo Global Technology 

(United States) Inc., Lenovo (United 

States) Inc., and Tesla, Inc. On 

September 5, 2024, Staff filed a response 

supporting the joint motion. No other 

responses were filed. 

On September 12, 2024, the presiding 

ALJ issued the subject ID granting the 

joint motion to terminate the 

investigation. Order No. 10 (Sept. 12, 

2024). The subject ID finds that the joint 

motion complies with Commission Rule 

210.21(b)(1) (19 CFR 210.21(b)) and that 

no extraordinary circumstances prevent 

granting the motion. The ID also finds 

that termination of the investigation 

based on settlement would not be 

contrary to the public interest. 

No petitions for review of the ID were 

filed. 

The Commission has determined not 

to review the subject ID (Order No. 10). 

The investigation is terminated. 

The Commission vote for this 

determination took place on October 4, 

2024. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 


lotter on DSK11XQN23PROD with NOTICES1